WallStreetZenWallStreetZen

NASDAQ: ACET
Adicet Bio Inc Stock

$2.10+0.10 (+5%)
Updated Apr 23, 2024
ACET Price
$2.10
Fair Value Price
$3.22
Market Cap
$172.52M
52 Week Low
$1.10
52 Week High
$7.50
P/E
-0.63x
P/B
1.01x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$142.66M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.22
Operating Cash Flow
-$94M
Beta
1.06
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ACET Overview

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACET scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACET ($2.10) is undervalued by 34.87% relative to our estimate of its Fair Value price of $3.22 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ACET ($2.10) is significantly undervalued by 34.87% relative to our estimate of its Fair Value price of $3.22 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ACET is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ACET due diligence checks available for Premium users.

Be the first to know about important ACET news, forecast changes, insider trades & much more!

ACET News

Valuation

ACET fair value

Fair Value of ACET stock based on Discounted Cash Flow (DCF)
Price
$2.10
Fair Value
$3.22
Undervalued by
34.87%
ACET ($2.10) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ACET ($2.10) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ACET is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACET price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.63x
Industry
16.46x
Market
41.92x

ACET price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.01x
Industry
5.93x
ACET is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACET's financial health

Profit margin

Revenue
$0.0
Net Income
-$29.5M
Profit Margin
0%
ACET's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$207.3M
Liabilities
$37.1M
Debt to equity
0.22
ACET's short-term assets ($162.27M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACET's short-term assets ($162.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACET's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ACET's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$23.5M
Investing
-$136.0k
Financing
$76.0k
ACET's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ACET vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ACET$172.52M+5.00%-0.63x1.01x
TELO$172.33M+3.84%-12.13x50.12x
GNFT$171.68M-5.87%-5.47x2.32x
CADL$173.44M+6.68%-4.51x13.61x
IVA$171.46M-0.30%-1.25x-4.92x

Adicet Bio Stock FAQ

What is Adicet Bio's quote symbol?

(NASDAQ: ACET) Adicet Bio trades on the NASDAQ under the ticker symbol ACET. Adicet Bio stock quotes can also be displayed as NASDAQ: ACET.

If you're new to stock investing, here's how to buy Adicet Bio stock.

What is the 52 week high and low for Adicet Bio (NASDAQ: ACET)?

(NASDAQ: ACET) Adicet Bio's 52-week high was $7.50, and its 52-week low was $1.10. It is currently -72% from its 52-week high and 90.91% from its 52-week low.

How much is Adicet Bio stock worth today?

(NASDAQ: ACET) Adicet Bio currently has 82,153,984 outstanding shares. With Adicet Bio stock trading at $2.10 per share, the total value of Adicet Bio stock (market capitalization) is $172.52M.

Adicet Bio stock was originally listed at a price of $118.16 in Jan 26, 2018. If you had invested in Adicet Bio stock at $118.16, your return over the last 6 years would have been -98.22%, for an annualized return of -48.92% (not including any dividends or dividend reinvestments).

How much is Adicet Bio's stock price per share?

(NASDAQ: ACET) Adicet Bio stock price per share is $2.10 today (as of Apr 23, 2024).

What is Adicet Bio's Market Cap?

(NASDAQ: ACET) Adicet Bio's market cap is $172.52M, as of Apr 24, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Adicet Bio's market cap is calculated by multiplying ACET's current stock price of $2.10 by ACET's total outstanding shares of 82,153,984.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.